Testing anakinra to improve recovery after stroke treatment
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a medicine called anakinra (usually used for inflammation) to see if it helps improve recovery after a stroke caused by a blocked artery that was successfully opened with a procedure. It aims to reduce brain damage and improve outcomes for patients who still have significant symptoms after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be between 18 and 80 years old.
- Stroke symptoms must have started within the past 24 hours (or last seen normal within that time).
- You should have had no major disability before the stroke (able to do daily activities independently).
- Stroke symptoms must be moderate to severe, as measured by a standard scale (NIHSS score 6-25).
- A scan must show a blockage in one of the major arteries (internal carotid or middle cerebral).
- You must have had a successful clot-removal procedure (thrombectomy) to open the blocked artery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a specific treatment (likely endovascular therapy) helps people who have a minor stroke caused by a blockage in a large brain artery. If you are eligible, you may receive this treatment within 24 hours of your stroke to try to improve your recovery.
This study tests a procedure called endovascular recanalization, which uses a small tube to open a blocked artery in the brain. It is for people who had a stroke or mini-stroke recently and are still having symptoms despite taking medication. The goal is to improve blood flow and reduce the chance of another stroke.
This trial checks if adding an interleukin-6 receptor inhibitor (a drug that reduces inflammation) to standard emergency clot removal can improve recovery for people with a severe stroke affecting the back part of the brain (posterior circulation). It is for patients who need urgent treatment within 24 hours of symptom onset.
This trial tests whether giving acetaminophen (a common pain and fever reliever) can improve recovery after a severe stroke caused by a blocked large artery in the brain, when patients have also had a procedure to reopen that artery. The medicine may help protect brain cells and reduce damage.
This trial tests an “intra-arterial” approach (a treatment delivered through an artery to the brain) for people with ischemic stroke who were not given clot-busting therapy or a clot-removal procedure. It aims to improve neurological recovery when there wasn’t reperfusion therapy, including in cases where symptoms worsen soon after stroke.
This trial tests whether adding anisodine, a medicine that may protect brain cells, helps people recover better after a stroke caused by a blocked large artery in the brain. It is given after a procedure to remove the clot.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.